Congrats to the ZEO team on delivering a highly encouraging PFS.
This document doesn’t just validate the commercial and technical strength of the AusPozz project — it effectively provides a valuation benchmark for potential acquirers.
”It is also possible that the Company could pursue other ‘value realisation’ strategies such as a sale, partial sale or joint venture of the project. If it does, this could materially reduce the Company’s proportionate ownership of the Project.”
A full or partial project sale remains a live and plausible scenario.
In the event the company sought to finance the project CAPEX via debt, I’d confidently bet most infrastructure lending teams at major banks would lend 80- 90%
For those who’ve been tracking ZEO’s movements — especially the rapid rise of SCM in the decarbonisation of cement — it’s hard to look past Holcim or even Boral as likely buyers. Both have been actively sampling AusPozz in recent months.
Timing could be key — the Chinese (via MSI) are also circling with a large DSO MOU, and any binding offtake deals could complicate a clean acquisition path.
The PFS is loaded with positives:
• $406m NPV (after tax)
• 42% IRR
• 20-year mine life
• $115m capex / 2.1 yr payback
• Q1 2029 full-scale AusPozz production
• DSO sales starting as early as Q1 next year • DFS in 6 months
• Sales price estimates of $403/t (AusPozz) and $196/t (DSO)
• 65 active sales/specifier leads already in play
This project is becoming increasingly strategic — both economically and environmentally — and we may not have to wait long before someone moves to secure it.
A hot space to watch in the months ahead.
- Forums
- ASX - By Stock
- Ann: AusPozz Project Preliminary Feasibility Study
ZEO
zeotech limited
Add to My Watchlist
2.86%
!
6.8¢

Congrats to the ZEO team on delivering a highly encouraging...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.8¢ |
Change
-0.002(2.86%) |
Mkt cap ! $127.8M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 6.6¢ | $80.75K | 1.181M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 111558 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 400236 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 111558 | 0.068 |
2 | 427636 | 0.066 |
5 | 521817 | 0.065 |
1 | 500000 | 0.064 |
2 | 129365 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 400236 | 1 |
0.075 | 10000 | 1 |
0.079 | 56000 | 1 |
0.080 | 199929 | 1 |
0.081 | 5681 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ZEO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online